114 related articles for article (PubMed ID: 27470342)
21. Anti-proliferation, cell cycle arrest and apoptosis induced by a natural xanthone from Gentianopsis paludosa Ma, in human promyelocytic leukemia cell line HL-60 cells.
Ding L; Liu B; Qi LL; Zhou QY; Hou Q; Li J; Zhang Q
Toxicol In Vitro; 2009 Apr; 23(3):408-17. PubMed ID: 19344684
[TBL] [Abstract][Full Text] [Related]
22. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
[TBL] [Abstract][Full Text] [Related]
23. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
[TBL] [Abstract][Full Text] [Related]
24. Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.
Pesakhov S; Khanin M; Studzinski GP; Danilenko M
Nutr Cancer; 2010; 62(6):811-24. PubMed ID: 20661831
[TBL] [Abstract][Full Text] [Related]
25. Wild carrot oil extract is selectively cytotoxic to human acute myeloid leukemia cells.
Tawil M; Bekdash A; Mroueh M; Daher CF; Abi-Habib RJ
Asian Pac J Cancer Prev; 2015; 16(2):761-7. PubMed ID: 25684522
[TBL] [Abstract][Full Text] [Related]
26. GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation.
Gupta K; Stefan T; Ignatz-Hoover J; Moreton S; Parizher G; Saunthararajah Y; Wald DN
Cancer Res; 2016 May; 76(9):2743-53. PubMed ID: 26964622
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological properties and protein binding capacity of phenolic extracts of some Venda medicinal plants used against cough and fever.
Mulaudzi RB; Ndhlala AR; Kulkarni MG; Van Staden J
J Ethnopharmacol; 2012 Aug; 143(1):185-93. PubMed ID: 22732728
[TBL] [Abstract][Full Text] [Related]
28. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
29. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
[TBL] [Abstract][Full Text] [Related]
30. p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Piedfer M; Bouchet S; Tang R; Billard C; Dauzonne D; Bauvois B
Biochim Biophys Acta; 2013 Jun; 1833(6):1316-28. PubMed ID: 23481040
[TBL] [Abstract][Full Text] [Related]
31. G1 arrest and caspase-mediated apoptosis in HL-60 cells by dichloromethane extract of Centrosema pubescens.
Ramadevi Mani S; Lakshmi BS
Am J Chin Med; 2010; 38(6):1143-59. PubMed ID: 21061467
[TBL] [Abstract][Full Text] [Related]
32. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation.
Gocek E; Marchwicka A; Baurska H; Chrobak A; Marcinkowska E
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):220-6. PubMed ID: 22789609
[TBL] [Abstract][Full Text] [Related]
33. [Inhibitory effect of flavonoids of puerarin on proliferation of different human acute myeloid leukemia cell lines in vitro].
Shao HM; Tang YH; Jiang PJ; Zhu HQ; Zhang YC; Ji JM; Ji O; Shen Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):296-9. PubMed ID: 20416155
[TBL] [Abstract][Full Text] [Related]
34. Perilla leaf, Perilla frutescens, induces apoptosis and G1 phase arrest in human leukemia HL-60 cells through the combinations of death receptor-mediated, mitochondrial, and endoplasmic reticulum stress-induced pathways.
Kwak CS; Yeo EJ; Moon SC; Kim YW; Ahn HJ; Park SC
J Med Food; 2009 Jun; 12(3):508-17. PubMed ID: 19627198
[TBL] [Abstract][Full Text] [Related]
35. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase.
McCabe MJ; Singh KP; Reddy SA; Chelladurai B; Pounds JG; Reiners JJ; States JC
J Pharmacol Exp Ther; 2000 Nov; 295(2):724-33. PubMed ID: 11046111
[TBL] [Abstract][Full Text] [Related]
38. Axolotl
Suleiman S; Di Fiore R; Cassar A; Formosa MM; Schembri-Wismayer P; Calleja-Agius J
Tumour Biol; 2020 Sep; 42(9):1010428320954735. PubMed ID: 32873193
[TBL] [Abstract][Full Text] [Related]
39. Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.
Chen-Deutsch X; Studzinski GP
Cell Cycle; 2012 Apr; 11(7):1364-73. PubMed ID: 22421156
[TBL] [Abstract][Full Text] [Related]
40. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.
Callens C; Coulon S; Naudin J; Radford-Weiss I; Boissel N; Raffoux E; Wang PH; Agarwal S; Tamouza H; Paubelle E; Asnafi V; Ribeil JA; Dessen P; Canioni D; Chandesris O; Rubio MT; Beaumont C; Benhamou M; Dombret H; Macintyre E; Monteiro RC; Moura IC; Hermine O
J Exp Med; 2010 Apr; 207(4):731-50. PubMed ID: 20368581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
